Abstract
2021 was another busy year for the nascent field of immunopsychiatry. A key premise of the contemporary agenda lies in bottom-up pathways: immune mechanisms can affect brain function and contribute to psychiatric illness. An argument follows that irrespective of their origins, these signals can be targeted therapeutically. In turn, there is seemingly a promise of novel precision therapeutics for common and often otherwise treatment-resistant psychiatric disorders. This optimistic vision is not unfounded; there is a growing body of observational, mechanistic, and interventional findings spanning multiple psychopathologies and immune mechanisms.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
